NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 79 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 110.59 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $13,000 | +30.0% | 96,425 | 0.0% | 0.00% | – |
| Q4 2018 | $10,000 | -54.5% | 96,425 | 0.0% | 0.00% | – |
| Q3 2018 | $22,000 | 0.0% | 96,425 | +0.3% | 0.00% | – |
| Q2 2018 | $22,000 | -66.2% | 96,125 | -46.1% | 0.00% | – |
| Q1 2018 | $65,000 | -5.8% | 178,465 | -7.2% | 0.00% | – |
| Q4 2017 | $69,000 | +72.5% | 192,361 | +99.5% | 0.00% | – |
| Q3 2017 | $40,000 | +100.0% | 96,439 | +141.1% | 0.00% | – |
| Q2 2017 | $20,000 | -16.7% | 40,000 | -2.4% | 0.00% | – |
| Q1 2017 | $24,000 | -25.0% | 41,000 | -18.7% | 0.00% | – |
| Q4 2016 | $32,000 | -31.9% | 50,400 | -1.3% | 0.00% | – |
| Q3 2016 | $47,000 | -2.1% | 51,049 | -43.6% | 0.00% | – |
| Q2 2016 | $48,000 | -34.2% | 90,549 | +18.8% | 0.00% | – |
| Q1 2016 | $73,000 | -19.8% | 76,211 | +11.7% | 0.00% | – |
| Q4 2015 | $91,000 | -43.8% | 68,232 | -4.2% | 0.00% | – |
| Q3 2015 | $162,000 | +33.9% | 71,195 | -4.8% | 0.00% | – |
| Q2 2015 | $121,000 | +34.4% | 74,772 | +29.7% | 0.00% | – |
| Q1 2015 | $90,000 | +69.8% | 57,650 | +105.9% | 0.00% | – |
| Q4 2014 | $53,000 | +103.8% | 27,993 | +43.3% | 0.00% | – |
| Q3 2014 | $26,000 | -23.5% | 19,535 | -14.4% | 0.00% | – |
| Q2 2014 | $34,000 | +61.9% | 22,826 | +105.6% | 0.00% | – |
| Q1 2014 | $21,000 | -8.7% | 11,102 | +2.8% | 0.00% | – |
| Q4 2013 | $23,000 | -46.5% | 10,802 | -32.5% | 0.00% | – |
| Q3 2013 | $43,000 | +22.9% | 16,002 | +22.1% | 0.00% | – |
| Q2 2013 | $35,000 | – | 13,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|